Sustained release formulations for the treatment of intraocular pressure of glaucoma
AssigneeIcon Bioscience, Inc.
InventorsVernon G. Wong, Mae W. Hu, Glenn T. Huang
Life of this patent
Estimating the term…
Abstract
The present embodiments provide for methods of treating elevated intraocular pressure or glaucoma using a sustained release medicament consisting of prostaglandin in benzyl benzoate that is injected intraocularly no more frequently than once every two months.
Claims12
A method of treating elevated intraocular pressure or glaucoma in a subject in need of such treatment comprising administering by intraocular injection into the vitreous or anterior chamber a unit dose of 5 μL to 60 μL, inclusive, of a liquid formulation consisting of about 0.1% to 5% prostaglandin in benzyl benzoate (w/w), inclusive, no more frequently than once every two months.
Dependencies are inferred from the claim text.